Clinical application of a physically and chemically processed human substitute for dura mater

Journal of Neurosurgery

Volumn 98, Issue 6, 2003, Pages 1198-1202

  Dufrane, Denis ^a,b   Marchal, Christophe ^a   Cornu, Olivier ^a   Raftopoulos, Christian ^a   Delloye, Christian ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Dural substitute; Fascia lata; Human allograft

Indexed keywords

BIOMATERIAL; COLLAGEN; DETERGENT;

ADOLESCENT; ADULT; AGED; ALLOGRAFT; ARTICLE; BACTERIAL TRANSMISSION; BIOCOMPATIBILITY; BRAIN MALFORMATION; BRAIN TUMOR; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DURA MATER; FASCIA LATA; FEMALE; FIBROBLAST; FOLLOW UP; FREEZE DRYING; GAMMA RADIATION; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN TISSUE; IMMUNITY; IMPLANTATION; INFECTION RISK; INFLAMMATION; INJURY; MALE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; SAFETY; SURGICAL WOUND; TRIGEMINUS NEURALGIA; VIRUS TRANSMISSION;

EID: 0038527130     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2003.98.6.1198     Document Type: Article

References (41)

1. Adegbite AB, Paine KW, Rozdilsky B: The role of neomembranes in formation of hematoma around Silastic dura substitute. Case report. J Neurosurg 58:295-297, 1983
2. Anastasescou M, Cornu O, Banse X, et al: Ethanol treatment of tendon allografts: a potential HIV inactivating procedure. Int Orthop 22:252-254, 1988
3. Brown P, Gibbs CJ Jr, Amyx HL, et al: Chemical disinfection of Creutzfeldt-Jakob disease virus. N Engl J Med 306:1279-1282, 1982
4. Brown P, Rohwer RG, Gajdusek DC: Sodium hydroxide decontamination of Creutzfeldt-Jakob disease virus. N Engl J Med 310:727, 1984 (Letter)
5. Buck BE, Malinin TI, Brown MD: Bone transplantation and human immunodeficiency virus. An estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin Orthop 240:129-136, 1989
6. Campbell DG, Li P, Stephenson AJ, et al: Sterilization of HIV by gamma irradiation. A bone allograft model. Int Orthop 18: 172-176, 1994
7. Campbell DG, Oakeshott RD: Bone allograft banking in South Australia. Aust N Z J Surg 65:865-869, 1995
8. Cohen AR, Aleksic S, Ransohoff J: Inflammatory reaction to synthetic dural substitute. Case report. J Neurosurg 70:633-635, 1989
9. Conrad EU, Gretch DR, Obermeyer KR, et al: Transmission of the hepatitis-C virus by tissue transplantation. J Bone Joint Surg Am 77:214-224, 1995
10. Conway B, Tomford W, Mankin HJ, et al: Radiosensitivity of HIV-1 - potential application to sterilization of bone allografts. AIDS 5:608-609, 1991
11. Deijkers RL, Bloem RM, Petit PL, et al: Contamination of bone allografts: analysis of incidence and predisposing factors. J Bone Joint Surg (Br) 79:161-166, 1997
12. Dormont D: Creutzfeldt-Jakob disease and transplantation: facts and fables. Transplant Proc 28:2931-2933, 1996
13. Dufrane D, Cornu O, Delloye C, et al: Physical and chemical processing for a human dura mater substitute. Biomaterials 23: 2979-2988, 2002
14. Eggen BM, Nordbo SA: Transmission of HCV by organ transplantation. N Engl J Med 326:411-413, 1992
15. Eismont FJ, Wiesel SW, Rothman RH: Treatment of dural tears associated with spinal surgery. J Bone Joint Surg (Am) 63: 1132-1136, 1981
16. Feinstone SM, Mihalik KB, Kamimura T, et al: Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform. Infect Immun 41:816-821, 1983
17. Fideler BM, Vangsness CT Jr, Moore T, et al: Effects of gamma irradiation on the human immunodeficiency virus. A study in frozen human bone-patellar ligament-bone grafts obtained from infected cadavera. J Bone Joint Surg (Am) 76:1032-1035, 1994
18. Forsell JH: Irradiation of musculoskeletal tissues, in Tomford WW (ed): Musculoskeletal Tissue Banking. New York: Raven Press, 1993, pp 149-180
19. Gummerlock MK, Kaufman HH, Narayan RK: FDA panel discussion on cadaver dura. J Neurosurg 73:310, 1990 (Letter)
20. Hernigou P, Marce D, Julieron A, et al: Stérilisation osseuse par irradiation et virus VIH. Rev Chir Orthop Reparatrice Appar Mot 79:445-451, 1993
21. Lelie PN, Zaaijer HL, Cuypers HT: Risk of virus transmission by tissue, blood and plasma products. Transplant Proc 28:2939, 1996
22. Loty B, Courpied JP, Tomeno B, et al: Bone allografts sterilised by irradiation. Biological properties, procurement and results of 150 massive allografts. Int Orthop 14:237-242, 1990
23. Lupi O: Prions in dermatology. J Am Acad Dermatol 46: 790-793, 2002
24. Masullo C, Pocchiari M, Macchi G, et al: Transmission of Creutzfeldt-Jakob disease by dural cadaveric graft. J Neurosurg 71: 954-955, 1989 (Letter)
25. Minami A, Ishii S, Ogino T, et al: Effect of the immunological antigenicity of the allogeneic tendons on tendon grafting. Hand 14: 111-119, 1982
26. Minami A, Usui M, Ishii S, et al: The in vivo effects of various immunoreactive treatments on allogeneic tendon grafts. J Hand Surg (Am) 8:888-893, 1983
27. Ng TH, Chan KH, Leung SY, et al: An unusual complication of silastic dural substitute: case report. Neurosurgery 27:491-493, 1990
28. Ohbayashi N, Inagawa T, Katoh Y, et al: Complication of silastic dural substitute 20 years after dural plasty. Surg Neurol 41: 338-341, 1994
29. Ongkiko CM Jr, Keller JT, Mayfield FH, et al: An unusual complication of Dura Film as a dural substitute. Report of two cases. J Neurosurg 60:1076-1079, 1984
30. Parizek J, Husek Z, Mericka P, et al: Ovine pericardium: a new material for duraplasty. J Neurosurg 84:508-513, 1996
31. Parizek J, Mericka P, Husek Z, et al: Detailed evaluation of 2959 allogeneic and xenogeneic dense connective tissue grafts (fascia lata, pericardium and dura mater) used in the course of 20 years for duraplasty in neurosurgery. Acta Neurochir 139:827-838, 1997
32. Pinkowski JL, Reiman PR, Chen SL: Human lymphocyte reaction to freeze-dried allograft and xenograft ligamentous tissue. Am J Sports Med 17:595-600, 1989
33. Pinkowski JL, Rodrigo JJ, Sharkey NA, et al: Immune response to nonspecific and altered tissue antigens in soft tissue allografts. Clin Orthop 326:80-85, 1996
34. Simpson D, Robson A: Recurrent subarachnoid bleeding in association with dural substitute. Report of three cases. J Neurosurg 60:408-409, 1984
35. Spire B, Barre-Sinoussi F, Montagnier L, et al: Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet 2:899-901, 1984
36. Spire B, Dormont D, Barre-Sinoussi F, et al: Inactivation of lymphadenopathy-associated virus by heat, gamma rays and ultraviolet light. Lancet 1:188-189, 1985
37. Thadani V, Penar PL, Partington J, et al: Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. J Neurosurg 69:766-769, 1988
38. Thammavaram KV, Benzel EC, Kesterson L: Fascia lata graft as a dural substitute in neurosurgery. South Med J 83:634-636, 1990
39. Unsal B, Ozcan G, Tuter G, et al: Evaluation of initial attachment of human gingival fibroblast cells to biodegradable membranes in vitro by light and scanning electron microscopy. J Oral Sci 41: 57-60, 1999
40. World Health Organization: Public health issues related to animal and human spongiform encephalopathies: memorandum from a WHO meeting. Bull WHO 70:183-190, 1992
41. Yamada K, Miyamoto S, Nagata I, et al: Development of a dural substitute from synthetic bioabsorbable polymers. J Neurosurg 86:1012-1017, 1997